Clinical Trial

Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis

Study acronym: PneumoTAV001
Recruiting
View on ClinicalTrials.gov →
Summary
This research is a clinical performance study of in vitro diagnostic device (IVD), a prospective, multicentre, open-label, case-control clinical investigation aimed at constructing a predictive model that allows results to be classified as positive or negative in relation to the probability of having lung cancer.
Trial Details
NCT Number NCT07465848
Lead Sponsor Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Collaborators: Life Length SL, Apices Soluciones S.L.
Conditions Lung Cancer (Diagnosis), Health Adult Subjects, Patient
Enrollment 1,200 participants
Start Date 2025-10-08
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-12